Palbociclib or Ribociclib with Aromatase Inhibitor in Post-menopausal Women with ER+/HER2– Advanced Breast Cancer? Real-world Overall Survival Evidence.
Saved in:
| Title: | Palbociclib or Ribociclib with Aromatase Inhibitor in Post-menopausal Women with ER+/HER2– Advanced Breast Cancer? Real-world Overall Survival Evidence. |
|---|---|
| Authors: | Tang, H.K.C.1 (AUTHOR), De Souza, K.2 (AUTHOR), Ahmad, O.1 (AUTHOR), Shafiq, T.1 (AUTHOR), Khan, S.1 (AUTHOR), Anand, A.1 (AUTHOR), Karim, S.1 (AUTHOR), Trivedi, S.1 (AUTHOR), Rahka, E.A.1,3 (AUTHOR), Madhusudan, S.1,3 (AUTHOR) |
| Source: | Clinical Oncology. Jun2023, Vol. 35 Issue 6, pe420-e420. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09366555 |
|---|---|
| DOI: | 10.1016/j.clon.2023.02.040 |
